Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
Objectives: Despite an increase in the use of mechanical circulatory support (MCS) devices for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised data directly comparing the use of Impella and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO). Methods...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/14/3955 |
_version_ | 1797433486623113216 |
---|---|
author | Riley J. Batchelor Andrew Wheelahan Wayne C. Zheng Dion Stub Yang Yang William Chan |
author_facet | Riley J. Batchelor Andrew Wheelahan Wayne C. Zheng Dion Stub Yang Yang William Chan |
author_sort | Riley J. Batchelor |
collection | DOAJ |
description | Objectives: Despite an increase in the use of mechanical circulatory support (MCS) devices for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised data directly comparing the use of Impella and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO). Methods: Electronic databases of MEDLINE, EMBASE and CENTRAL were systematically searched in November 2021. Studies directly comparing the use of Impella (CP, 2.5 or 5.0) with VA-ECMO for AMI-CS were included. Studies examining other modalities of MCS, or other causes of cardiogenic shock, were excluded. The primary outcome was in-hospital mortality. Results: No randomised trials comparing VA-ECMO to Impella in patients with AMI-CS were identified. Six cohort studies (five retrospective and one prospective) were included for systematic review. All studies, including 7093 patients, were included in meta-analysis. Five studies reported in-hospital mortality, which, when pooled, was 42.4% in the Impella group versus 50.1% in the VA-ECMO group. Impella support for AMI-CS was associated with an 11% relative risk reduction in in-hospital mortality compared to VA-ECMO (risk ratio 0.89; 95% CI 0.83–0.96, I<sup>2</sup> 0%). Of the six studies, three studies also adjusted outcome measures via propensity-score matching with reported reductions in in-hospital mortality with Impella compared to VA-ECMO (risk ratio 0.72; 95% CI 0.59–0.86, I<sup>2</sup> 35%). Pooled analysis of five studies with 6- or 12-month mortality data reported a 14% risk reduction with Impella over the medium-to-long-term (risk ratio 0.86; 95% CI 0.76–0.97, I<sup>2</sup> 0%). Conclusions: There is no high-level evidence comparing VA-ECMO and Impella in AMI-CS. In available observation studies, MCS with Impella was associated with a reduced risk of in-hospital and medium-term mortality as compared to VA-ECMO. |
first_indexed | 2024-03-09T10:17:41Z |
format | Article |
id | doaj.art-c000dc978d644ab9af704feb079f66e1 |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-09T10:17:41Z |
publishDate | 2022-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-c000dc978d644ab9af704feb079f66e12023-12-01T22:17:46ZengMDPI AGJournal of Clinical Medicine2077-03832022-07-011114395510.3390/jcm11143955Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-AnalysisRiley J. Batchelor0Andrew Wheelahan1Wayne C. Zheng2Dion Stub3Yang Yang4William Chan5Department of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaDepartment of Cardiology, Western Health, Melbourne 3004, AustraliaDepartment of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaDepartment of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaIntensive Care Unit, Western Health, Melbourne 3004, AustraliaDepartment of Cardiology, The Alfred Hospital, 55 Commercial Road, Melbourne 3004, AustraliaObjectives: Despite an increase in the use of mechanical circulatory support (MCS) devices for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised data directly comparing the use of Impella and veno-arterial extra-corporeal membrane oxygenation (VA-ECMO). Methods: Electronic databases of MEDLINE, EMBASE and CENTRAL were systematically searched in November 2021. Studies directly comparing the use of Impella (CP, 2.5 or 5.0) with VA-ECMO for AMI-CS were included. Studies examining other modalities of MCS, or other causes of cardiogenic shock, were excluded. The primary outcome was in-hospital mortality. Results: No randomised trials comparing VA-ECMO to Impella in patients with AMI-CS were identified. Six cohort studies (five retrospective and one prospective) were included for systematic review. All studies, including 7093 patients, were included in meta-analysis. Five studies reported in-hospital mortality, which, when pooled, was 42.4% in the Impella group versus 50.1% in the VA-ECMO group. Impella support for AMI-CS was associated with an 11% relative risk reduction in in-hospital mortality compared to VA-ECMO (risk ratio 0.89; 95% CI 0.83–0.96, I<sup>2</sup> 0%). Of the six studies, three studies also adjusted outcome measures via propensity-score matching with reported reductions in in-hospital mortality with Impella compared to VA-ECMO (risk ratio 0.72; 95% CI 0.59–0.86, I<sup>2</sup> 35%). Pooled analysis of five studies with 6- or 12-month mortality data reported a 14% risk reduction with Impella over the medium-to-long-term (risk ratio 0.86; 95% CI 0.76–0.97, I<sup>2</sup> 0%). Conclusions: There is no high-level evidence comparing VA-ECMO and Impella in AMI-CS. In available observation studies, MCS with Impella was associated with a reduced risk of in-hospital and medium-term mortality as compared to VA-ECMO.https://www.mdpi.com/2077-0383/11/14/3955acute myocardial infarctioncardiogenic shockVA-ECMOImpellamechanical circulatory support |
spellingShingle | Riley J. Batchelor Andrew Wheelahan Wayne C. Zheng Dion Stub Yang Yang William Chan Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis Journal of Clinical Medicine acute myocardial infarction cardiogenic shock VA-ECMO Impella mechanical circulatory support |
title | Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis |
title_full | Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis |
title_fullStr | Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis |
title_short | Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis |
title_sort | impella versus venoarterial extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock a systematic review and meta analysis |
topic | acute myocardial infarction cardiogenic shock VA-ECMO Impella mechanical circulatory support |
url | https://www.mdpi.com/2077-0383/11/14/3955 |
work_keys_str_mv | AT rileyjbatchelor impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis AT andrewwheelahan impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis AT wayneczheng impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis AT dionstub impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis AT yangyang impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis AT williamchan impellaversusvenoarterialextracorporealmembraneoxygenationforacutemyocardialinfarctioncardiogenicshockasystematicreviewandmetaanalysis |